$IPD vcp?Lovely stage 2 accumulation. Monthly close above 22 and game on. Monthly close above 21.5 sets the taret up for 41.5c.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.010AUD
−19.79 MAUD
10.32 MAUD
1.72 B
About IMPEDIMED LIMITED
Sector
Industry
CEO
Parmjot Bains
Website
Headquarters
Pinkenba
Founded
1999
ISIN
AU000000IPD8
FIGI
BBG000TD2B75
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IPD is 0.053 AUD — it has increased by 1.85% in the past 24 hours. Watch IMPEDIMED LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange IMPEDIMED LIMITED stocks are traded under the ticker IPD.
IPD stock has fallen by −3.51% compared to the previous week, the month change is a −5.17% fall, over the last year IMPEDIMED LIMITED has showed a −51.82% decrease.
We've gathered analysts' opinions on IMPEDIMED LIMITED future price: according to them, IPD price has a max estimate of 0.19 AUD and a min estimate of 0.09 AUD. Watch IPD chart and read a more detailed IMPEDIMED LIMITED stock forecast: see what analysts think of IMPEDIMED LIMITED and suggest that you do with its stocks.
IPD stock is 3.77% volatile and has beta coefficient of 0.42. Track IMPEDIMED LIMITED stock price on the chart and check out the list of the most volatile stocks — is IMPEDIMED LIMITED there?
Today IMPEDIMED LIMITED has the market capitalization of 109.25 M, it has decreased by −5.26% over the last week.
Yes, you can track IMPEDIMED LIMITED financials in yearly and quarterly reports right on TradingView.
IMPEDIMED LIMITED is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
IPD earnings for the last half-year are −0.01 AUD per share, whereas the estimation was −0.01 AUD, resulting in a 16.67% surprise. The estimated earnings for the next half-year are 0.00 AUD per share. See more details about IMPEDIMED LIMITED earnings.
IMPEDIMED LIMITED revenue for the last half-year amounts to 6.35 M AUD, despite the estimated figure of 5.50 M AUD. In the next half-year revenue is expected to reach 7.70 M AUD.
IPD net income for the last half-year is −10.07 M AUD, while the previous report showed −9.72 M AUD of net income which accounts for −3.64% change. Track more IMPEDIMED LIMITED financial stats to get the full picture.
No, IPD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 1, 2024, the company has 83.00 employees. See our rating of the largest employees — is IMPEDIMED LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMPEDIMED LIMITED EBITDA is −21.41 M AUD, and current EBITDA margin is −210.50%. See more stats in IMPEDIMED LIMITED financial statements.
Like other stocks, IPD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMPEDIMED LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMPEDIMED LIMITED technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMPEDIMED LIMITED stock shows the sell signal. See more of IMPEDIMED LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.